Therefore, further experimental and clinical data are now needed to support a more precise role for these signals in BPD, as well as long-term follow-up results to validate the value of targeted SIRT1 therapy for BPD. The gene discussed is SIRT1; the disease is bronchopulmonary dysplasia.